Methylprednisolone acetate vs Adalimumab
National NHS prescribing compared (Prescription Cost Analysis)
Methylprednisolone acetate was dispensed 24,011.0× as often as Adalimumab in June 2026 — 72,033 items versus 3 in England.
72,033items
Methylprednisolone acetate · June 2026
NHSBSA Prescription Cost Analysis
3items
Adalimumab · June 2026
NHSBSA Prescription Cost Analysis
Figure 1. Methylprednisolone acetate versus Adalimumab: national items dispensed by month
▬ Methylprednisolone acetate · ╌ Adalimumab
Source: NHSBSA Prescription Cost Analysis, to June 2026
| Measure | Methylprednisolone acetate | Adalimumab |
|---|---|---|
| Items, June 2026 | 72,033 | 3 |
| Items, last 12 months | 765,230 | 40 |
| Net ingredient cost, June 2026 | £350,309 | £2,042 |
See the full profile for Methylprednisolone acetate or Adalimumab.